Oncology PracticeFDA panel votes against 2 cancer indications but backs 4 of 6April 30, 2021ImmunotherapyBreast CancerGenitourinary CancerGastrointestinal CancerPatient & Survivor CareMetastatic Breast Cancer
Higher BMI linked to risk for second primary cancer in breast cancer survivorsApril 29, 2021Breast Cancer
Overtreatment does not benefit older patients with early ER+ breast cancerApril 29, 2021Breast Cancer
Breast cancer: Detrimental effects of adjuvant chemotherapy on QoL in older patients subside after 3 yearsApril 29, 2021Breast Cancer
Pembrolizumab plus eribulin shows activity in HR+, HER2-negative breast cancerApril 29, 2021Breast Cancer
Hematology NewsAHA statement flags CV risk of hormonal cancer therapiesApril 29, 2021Mixed TopicsBreast CancerGenitourinary Cancer
Oncology PracticeFDA panel backs atezolizumab for mTNBC – at least for nowApril 28, 2021Breast CancerMetastatic Breast Cancer
Oncology PracticeCell-free DNA improves response prediction in breast cancerApril 21, 2021Breast CancerMetastatic Breast Cancer
Oncology PracticeQuicker fertility rebound in young women with breast cancerApril 19, 2021Breast Cancer
